CRIXIVAN

Product NDC: 0006-0573
11-digit product format: 000060573
Labeler code: 0006
Product ID: 0006-0573_2f1ee2da-8e76-4c4e-8006-285449f74f1b
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: indinavir sulfate
Dosage form: CAPSULE
Route: ORAL
Labeler: Merck Sharp & Dohme Corp.
Application: NDA020685
Marketing category: NDA
Marketing start: 1996-03-13
Marketing end: 0000-00-00
Substance: INDINAVIR SULFATE
Active strength: 400 mg/1
Pharmacologic classes: HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	0006-0573		D	Discontinued by firm		2026-10-12
excluded package	package	0006-0573	0006-0573-62	D	Discontinued by firm		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0006-0573-62	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0006-0573-62	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0006-0573-62	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0006-0573-62	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0006-0573-62	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0006-0573-62	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0006-0573-62	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0006-0573-62	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0006-0573-62	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0006-0573-62	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0006-0573-62	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0006-0573-62	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N020685-001	CRIXIVAN	INDINAVIR SULFATE	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13
N020685-003	CRIXIVAN	INDINAVIR SULFATE	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13
N020685-005	CRIXIVAN	INDINAVIR SULFATE	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17
N020685-006	CRIXIVAN	INDINAVIR SULFATE	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020685-001	CRIXIVAN	EQ 400MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020685-003	CRIXIVAN	EQ 200MG BASE	CAPSULE / ORAL	RLD	1996-03-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020685-005	CRIXIVAN	EQ 333MG BASE	CAPSULE / ORAL		1998-12-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020685-006	CRIXIVAN	EQ 100MG BASE	CAPSULE / ORAL		2000-04-19	`5bbf6a4d5a75…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N020685-001	6689761	2021-02-10	U-554	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020685-003	6689761	2021-02-10	U-554	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020685-005	6689761	2021-02-10	U-554	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020685-006	6689761	2021-02-10	U-554	`74a2ff9319b5…`
2021-12-28 21:50 UTC	2021-12	N020685-001	6689761	2021-02-10	U-554	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N020685-003	6689761	2021-02-10	U-554	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N020685-005	6689761	2021-02-10	U-554	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N020685-006	6689761	2021-02-10	U-554	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020685-001	6689761	2021-02-10	U-554	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020685-003	6689761	2021-02-10	U-554	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020685-005	6689761	2021-02-10	U-554	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020685-006	6689761	2021-02-10	U-554	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020685-001	6689761	2021-02-10	U-554	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N020685-003	6689761	2021-02-10	U-554	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N020685-005	6689761	2021-02-10	U-554	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N020685-006	6689761	2021-02-10	U-554	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020685-001	6689761	2021-02-10	U-554	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N020685-003	6689761	2021-02-10	U-554	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N020685-005	6689761	2021-02-10	U-554	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N020685-006	6689761	2021-02-10	U-554	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020685-001	6689761	2021-02-10	U-554	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N020685-003	6689761	2021-02-10	U-554	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N020685-005	6689761	2021-02-10	U-554	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N020685-006	6689761	2021-02-10	U-554	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020685-001	6689761	2021-02-10	U-554	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N020685-003	6689761	2021-02-10	U-554	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N020685-005	6689761	2021-02-10	U-554	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N020685-006	6689761	2021-02-10	U-554	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020685-001	6689761	2021-02-10	U-554	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N020685-003	6689761	2021-02-10	U-554	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N020685-005	6689761	2021-02-10	U-554	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N020685-006	6689761	2021-02-10	U-554	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020685-001	6689761	2021-02-10	U-554	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N020685-003	6689761	2021-02-10	U-554	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N020685-005	6689761	2021-02-10	U-554	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N020685-006	6689761	2021-02-10	U-554	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
eed3583e-78db-412f-aba7-02811a2dc6a8	Product name	1	20150204

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0006-0573-18	EA - Each	0006-0573	7c3a9894-de1d-4f03-ad55-9263f5a9b003	1	2013-02-11
0006-0573-42	EA - Each	0006-0573	307ff0ef-46f0-4206-a6ff-c5eefcf0f5f1	1	2013-02-11
0006-0573-54	EA - Each	0006-0573	21b0f3cc-4bd2-409f-bd23-8801ab31a88d	1	2012-07-24
0006-0573-62	EA - Each	0006-0573	4b7e8d81-7e29-407c-afd9-a98ecf1b814e	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
INDINAVIR SULFATE	ACTIVE INGREDIENT	771H53976Q	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [MERCK SHARP & DOHME CORP.]	21
INDINAVIR ANHYDROUS	ACTIVE MOIETY	9MG78X43ZT	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [MERCK SHARP & DOHME CORP.]	21
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [MERCK SHARP & DOHME CORP.]	21
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [MERCK SHARP & DOHME CORP.]	21
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [MERCK SHARP & DOHME CORP.]	21
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [MERCK SHARP & DOHME CORP.]	21
INDINAVIR SULFATE	ACTIVE INGREDIENT	771H53976Q	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	3
INDINAVIR	ACTIVE MOIETY	5W6YA9PKKH	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	3
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	3
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	3
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	3
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STATE OF FLORIDA DOH CENTRAL PHARMACY]	3
INDINAVIR SULFATE	ACTIVE INGREDIENT	771H53976Q	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STAT RX USA LLC]	1
INDINAVIR SULFATE	ACTIVE INGREDIENT	771H53976Q	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [REBEL DISTRIBUTORS CORP]	1
INDINAVIR	ACTIVE MOIETY	5W6YA9PKKH	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [REBEL DISTRIBUTORS CORP]	1
INDINAVIR ANHYDROUS	ACTIVE MOIETY	9MG78X43ZT	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STAT RX USA LLC]	1
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [REBEL DISTRIBUTORS CORP]	1
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STAT RX USA LLC]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STAT RX USA LLC]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [REBEL DISTRIBUTORS CORP]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [REBEL DISTRIBUTORS CORP]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STAT RX USA LLC]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [REBEL DISTRIBUTORS CORP]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [REBEL DISTRIBUTORS CORP]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [REBEL DISTRIBUTORS CORP]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CRIXIVAN (INDINAVIR SULFATE) CAPSULE [STAT RX USA LLC]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
771H53976Q	INDINAVIR SULFATE	157810-81-6	INDINAVIR SULFATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
153128	Crixivan 400 MG Oral Capsule	PSN	702727cb-3eff-425b-9573-031332849430	3
310988	indinavir sulfate 400 MG Oral Capsule	PSN	702727cb-3eff-425b-9573-031332849430	3
153128	indinavir 400 MG Oral Capsule [Crixivan]	SBD	702727cb-3eff-425b-9573-031332849430	3
310988	indinavir 400 MG Oral Capsule	SCD	702727cb-3eff-425b-9573-031332849430	3
153128	Crixivan 400 MG (as indinavir sulfate 500 MG) Oral Capsule	SY	702727cb-3eff-425b-9573-031332849430	3
153128	Crixivan 400 MG Oral Capsule	SY	702727cb-3eff-425b-9573-031332849430	3
310988	indinavir 400 MG (indinavir sulfate 500 MG) Oral Capsule	SY	702727cb-3eff-425b-9573-031332849430	3
153128	Crixivan 400 MG Oral Capsule	PSN	01c5574c-1056-49c6-af20-e950db3f4139	1
153128	Crixivan 400 MG Oral Capsule	PSN	83aeddf8-6fed-487c-858b-2240f0a0e8af	1
310988	indinavir sulfate 400 MG Oral Capsule	PSN	01c5574c-1056-49c6-af20-e950db3f4139	1
310988	indinavir sulfate 400 MG Oral Capsule	PSN	83aeddf8-6fed-487c-858b-2240f0a0e8af	1
153128	indinavir 400 MG Oral Capsule [Crixivan]	SBD	83aeddf8-6fed-487c-858b-2240f0a0e8af	1
153128	indinavir 400 MG Oral Capsule [Crixivan]	SBD	01c5574c-1056-49c6-af20-e950db3f4139	1
310988	indinavir 400 MG Oral Capsule	SCD	01c5574c-1056-49c6-af20-e950db3f4139	1
310988	indinavir 400 MG Oral Capsule	SCD	83aeddf8-6fed-487c-858b-2240f0a0e8af	1
153128	Crixivan 400 MG (as indinavir sulfate 500 MG) Oral Capsule	SY	83aeddf8-6fed-487c-858b-2240f0a0e8af	1
153128	Crixivan 400 MG (as indinavir sulfate 500 MG) Oral Capsule	SY	01c5574c-1056-49c6-af20-e950db3f4139	1
153128	Crixivan 400 MG Oral Capsule	SY	83aeddf8-6fed-487c-858b-2240f0a0e8af	1
153128	Crixivan 400 MG Oral Capsule	SY	01c5574c-1056-49c6-af20-e950db3f4139	1
310988	indinavir 400 MG (indinavir sulfate 500 MG) Oral Capsule	SY	01c5574c-1056-49c6-af20-e950db3f4139	1
310988	indinavir 400 MG (indinavir sulfate 500 MG) Oral Capsule	SY	83aeddf8-6fed-487c-858b-2240f0a0e8af	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0006-0573-62	00006057362	180 CAPSULE in 1 BOTTLE (0006-0573-62)	180 capsule	1996-03-13	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
CRIXIVAN ® (INDINAVIR SULFATE) CAPSULES	Merck Sharp & Dohme Corp.	2020-11-03	HUMAN PRESCRIPTION DRUG LABEL	26
CRIXIVAN ® (INDINAVIR SULFATE) CAPSULES	STAT Rx USA LLC \| PSS World Medical Inc.	2012-06-14	HUMAN PRESCRIPTION DRUG LABEL	1
CRIXIVAN ® (INDINAVIR SULFATE) CAPSULES	Rebel Distributors Corp	2010-09-24	HUMAN PRESCRIPTION DRUG LABEL	1
CRIXIVAN ® (INDINAVIR SULFATE) CAPSULES	State of Florida DOH Central Pharmacy	2010-08-18	HUMAN PRESCRIPTION DRUG LABEL	3